The Cigna Group
Location
Connecticut
Founded
2018-02-28
Website
Risk Signals
7763 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Hospital and Medical Service Plans), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about The Cigna Group
Live alerts from global media, monitored by Business Radar
2025-02-11 (marketbeat.com)
Balentine LLC Buys 2,886 Shares of Arista Networks, Inc. (NYSE:ANET)
Balentine LLC raised its position in shares of Arista Networks, Inc. (NYSE:ANET - Free Report) by 300.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,848 shares of the technology company's stock after acquiring an a
Read more
2025-01-23 (benzinga.com)
Here's How Much You Would Have Made Owning Cigna Stock In The Last 20 Years - Cigna (NYSE:CI) -
Cigna CI has outperformed the market over the past 20 years by 4.12% on an annualized basis producing an average annual return of 12.64%. Currently, Cigna has a market capitalization of $80.40 billion.
Read more
2025-01-08 (benzinga.com)
Here's How Much $1000 Invested In Cigna 15 Years Ago Would Be Worth Today - Cigna (NYSE:CI) -
Cigna CI has outperformed the market over the past 15 years by 3.0% on an annualized basis producing an average annual return of 14.52%. Currently, Cigna has a market capitalization of $77.50 billion.
Read more
2024-12-23 (trefis.com)
Cigna (CI) Valuation: CI Stock Looks Appropriately Priced With $265 Price Estimate |
. Debug Trail. Untitled Section. Valuation Derived From: [1] Price To Sales Ratio (P/S) Based Estimate. [1] Price To Sales Ratio (P/S) Based Estimate: $null. [i] Estimating Cigna Price To Sales Ratio Of 0.0. What Price to Sales Ratio Makes Sense? [ii] Estimating Cigna Revenue Per Share (FY2023E) Of $null. What Revenue Growth Makes Sense? [2] Price To Earnings Ratio (P/E) Based Estimate: $0.0 [i] CI Price To Earnings Ratio (0.0) x [ii]FY 2024E Earnings Per Share ($null). [i] Estimating Cigna Price To Earnings Ratio Of 0.0. What Price to Earnings Ratio Makes Sense? [ii] Estimating Cigna Earnings Per Share (FY2024E) of $null. Net Income (FY2024E) = Revenue (FY2024E) x Net Margin (FY2024E). Making Sense of Cigna Valuation. More from Trefis. Cigna Insights. Invest in Market-Beating Trefis Portfolios.
Read more
2024-11-19 (trefis.com)
The Cigna Group (CI) Valuation: CI Stock Looks Appropriately Priced With $320 Price Estimate
. Debug Trail. Untitled Section. Valuation Derived From: [1] Price To Sales Ratio (P/S) Based Estimate [2] Price To Earnings Ratio (P/E) Based Estimate. [1] Price To Sales Ratio (P/S) Based Estimate: $350.00. [i] Estimating The Cigna Group Price To Sales Ratio Of 0.4. What Price to Sales Ratio Makes Sense? [ii] Estimating The Cigna Group Revenue Per Share (FY2023E) Of $807.00. What Revenue Growth Makes Sense? [2] Price To Earnings Ratio (P/E) Based Estimate: $455.0 [i] CI Price To Earnings Ratio (15.9) x [ii]FY 2024E Earnings Per Share ($28.51). [i] Estimating The Cigna Group Price To Earnings Ratio Of 15.9. What Price to Earnings Ratio Makes Sense? [ii] Estimating The Cigna Group Earnings Per Share (FY2024E) of $28.51. Net Income (FY2024E) = Revenue (FY2024E) x Net Margin (FY2024E). Making Sense of The Cigna Group Valuation. More from Trefis. The Cigna Group Insights. Invest in Market-Beating Trefis Portfolios.
Read more
2024-11-02 (marketbeat.com)
Silvant Capital Management LLC Sells 54,050 Shares of Apollo Global Management, Inc. (NYSE:APO)
Silvant Capital Management LLC cut its holdings in Apollo Global Management, Inc. (NYSE:APO - Free Report) by 54.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,050 share
Read more
2024-10-13 (etfdailynews.com)
Park Avenue Securities LLC Has $443,000 Stock Position in Teck Resources Limited (NYSE:TECK)
Park Avenue Securities LLC increased its position in Teck Resources Limited (NYSE:TECK – Free Report) (TSE:TECK) by 8.7% in the third quarter, Holdings Channel.com reports. The firm owned 8,474 shares of the basic materials company’s stock after acquiring an additional 680 shares during the period.
Read more
2024-10-04 (fortune.com)
The pharmacy benefit management sector just might be set for a VC-backed shakeup, says Rightway CEO and cofounder Jordan Feldman
Jordan Feldman, CEO of Thrive-backed Rightway, says there’s an opportunity for disruption in the pharmacy benefits management sector.
Read more
2024-09-30 (chartmill.com)
NYSE:CI is showing good growth, while it is not too expensive.
For those who appreciate growth without the sticker shock, THE CIGNA GROUP (NYSE:CI) is worth considering.
Read more
2024-09-14 (marketbeat.com)
GHP Investment Advisors Inc. Has $4.13 Million Stock Holdings in CGI Inc. (NYSE:GIB)
GHP Investment Advisors Inc. grew its holdings in CGI Inc. (NYSE:GIB - Free Report) (TSE:GIB.A) by 14.4% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 41,348 shares of the technology company's stock after
Read more
2024-07-22 (quantisnow.com)
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 6.54% on an annualized basis producing an average annual return of 14.94%. Currently, Cigna Group has a market capitalization of $95.40 billion. Buying$ 100 In CI: If an investor had bought$ 100 of CI stock 20 years ago, it
Read more
2024-07-12 (kffhealthnews.org)
As Big PBMs Dangle On A Hook, Smaller Players Surface For A Bite
As Modern Healthcare explains, the newer entrants are trying to set themselves apart from giants CVS, Cigna, and UnitedHealth and are passing along drug rebates, disclosing cost negotiations, reimbursing pharmacies at higher rates, and more.
Read more